Ultragenyx Pharmaceutical Inc. buy Stifel Nicolaus
Start price
31.05.24
/
50%
€37.00
Target price
31.05.25
€116.79
Performance (%)
44.59%
Price
17.09.24
€52.00
Summary
This prediction is currently active. The BUY prediction by Stifel_Nicolaus for Ultragenyx Pharmaceutical Inc. has seen massive gains of 44.59%. This prediction currently runs until 31.05.25. The prediction end date can be changed by Stifel_Nicolaus at any time. Stifel_Nicolaus has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Ultragenyx Pharmaceutical Inc. | 4.950% | 4.950% |
iShares Core DAX® | 1.887% | 1.967% |
iShares Nasdaq 100 | 2.316% | -1.227% |
iShares Nikkei 225® | 1.134% | 0.390% |
iShares S&P 500 | 1.821% | 0.790% |
Comments by Stifel_Nicolaus for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its price target raised by analysts at Stifel Nicolaus from $124.00 to $127.00. They now have a "buy" rating on the stock.
Ratings data for RARE provided by MarketBeat